Andexanet Alfa Vs. Four-Factor PCC: Is Andexanet Alfa Worth The Hype?
Background: Oral factor Xa inhibitors (FXi) have been associated with major and fatal bleeding events, including intracranial hemorrhage (ICH). In randomized controlled trials, both rivaroxaban...